These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1315 related articles for article (PubMed ID: 25194353)
21. Novel mesoporous silica-based antibiotic releasing scaffold for bone repair. Shi X; Wang Y; Ren L; Zhao N; Gong Y; Wang DA Acta Biomater; 2009 Jun; 5(5):1697-707. PubMed ID: 19217361 [TBL] [Abstract][Full Text] [Related]
22. The effect of nanoparticle properties, detection method, delivery route and animal model on poly(lactic-co-glycolic) acid nanoparticles biodistribution in mice and rats. Simon LC; Sabliov CM Drug Metab Rev; 2014 May; 46(2):128-41. PubMed ID: 24303927 [TBL] [Abstract][Full Text] [Related]
23. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin. Yadav AK; Mishra P; Mishra AK; Mishra P; Jain S; Agrawal GP Nanomedicine; 2007 Dec; 3(4):246-57. PubMed ID: 18068091 [TBL] [Abstract][Full Text] [Related]
24. Development and characterization of hyaluronic acid decorated PLGA nanoparticles for delivery of 5-fluorouracil. Yadav AK; Agarwal A; Rai G; Mishra P; Jain S; Mishra AK; Agrawal H; Agrawal GP Drug Deliv; 2010 Nov; 17(8):561-72. PubMed ID: 20738221 [TBL] [Abstract][Full Text] [Related]
26. Preparation and characterization of teniposide PLGA nanoparticles and their uptake in human glioblastoma U87MG cells. Mo L; Hou L; Guo D; Xiao X; Mao P; Yang X Int J Pharm; 2012 Oct; 436(1-2):815-24. PubMed ID: 22846410 [TBL] [Abstract][Full Text] [Related]
27. Bisphosphonate-coated BSA nanoparticles lack bone targeting after systemic administration. Wang G; Kucharski C; Lin X; Uludağ H J Drug Target; 2010 Sep; 18(8):611-26. PubMed ID: 20158316 [TBL] [Abstract][Full Text] [Related]
28. Development of poly(lactic-co-glycolic) acid nanoparticles-embedded hyaluronic acid-ceramide-based nanostructure for tumor-targeted drug delivery. Park JH; Lee JY; Termsarasab U; Yoon IS; Ko SH; Shim JS; Cho HJ; Kim DD Int J Pharm; 2014 Oct; 473(1-2):426-33. PubMed ID: 25079433 [TBL] [Abstract][Full Text] [Related]
29. Construction and evaluation of Fe₃O₄-based PLGA nanoparticles carrying rtPA used in the detection of thrombosis and in targeted thrombolysis. Zhou J; Guo D; Zhang Y; Wu W; Ran H; Wang Z ACS Appl Mater Interfaces; 2014 Apr; 6(8):5566-76. PubMed ID: 24693875 [TBL] [Abstract][Full Text] [Related]
30. Novel PLGA-based nanoparticles for the oral delivery of insulin. Malathi S; Nandhakumar P; Pandiyan V; Webster TJ; Balasubramanian S Int J Nanomedicine; 2015; 10():2207-18. PubMed ID: 25848248 [TBL] [Abstract][Full Text] [Related]
31. [Experimental studies on a new bone tissue engineered scaffold biomaterials combined with cultured marrow stromal stem cells in vitro]. Pan H; Zheng Q; Guo X Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2007 Jan; 21(1):65-9. PubMed ID: 17305008 [TBL] [Abstract][Full Text] [Related]
32. Alendronate conjugated nanoparticles for calcification targeting. Li N; Song J; Zhu G; Shi X; Wang Y Colloids Surf B Biointerfaces; 2016 Jun; 142():344-350. PubMed ID: 26970822 [TBL] [Abstract][Full Text] [Related]
33. Enhancing alendronate release from a novel PLGA/hydroxyapatite microspheric system for bone repairing applications. Shi X; Wang Y; Ren L; Gong Y; Wang DA Pharm Res; 2009 Feb; 26(2):422-30. PubMed ID: 18979188 [TBL] [Abstract][Full Text] [Related]
34. Effects of functionalization of PLGA-[Asp-PEG]n copolymer surfaces with Arg-Gly-Asp peptides, hydroxyapatite nanoparticles, and BMP-2-derived peptides on cell behavior in vitro. Pan H; Zheng Q; Yang S; Guo X J Biomed Mater Res A; 2014 Dec; 102(12):4526-35. PubMed ID: 24677783 [TBL] [Abstract][Full Text] [Related]
35. Modified nanoprecipitation method to fabricate DNA-loaded PLGA nanoparticles. Niu X; Zou W; Liu C; Zhang N; Fu C Drug Dev Ind Pharm; 2009 Nov; 35(11):1375-83. PubMed ID: 19832638 [TBL] [Abstract][Full Text] [Related]
36. Multifunctional poly(D,L-lactide-co-glycolide)/montmorillonite (PLGA/MMT) nanoparticles decorated by Trastuzumab for targeted chemotherapy of breast cancer. Sun B; Ranganathan B; Feng SS Biomaterials; 2008 Feb; 29(4):475-86. PubMed ID: 17953985 [TBL] [Abstract][Full Text] [Related]
37. Surface modified PLGA nanoparticles for brain targeting of Bacoside-A. Jose S; Sowmya S; Cinu TA; Aleykutty NA; Thomas S; Souto EB Eur J Pharm Sci; 2014 Oct; 63():29-35. PubMed ID: 25010261 [TBL] [Abstract][Full Text] [Related]
38. Facile fabrication of poly(L-lactic acid)-grafted hydroxyapatite/poly(lactic-co-glycolic acid) scaffolds by Pickering high internal phase emulsion templates. Hu Y; Gu X; Yang Y; Huang J; Hu M; Chen W; Tong Z; Wang C ACS Appl Mater Interfaces; 2014 Oct; 6(19):17166-75. PubMed ID: 25243730 [TBL] [Abstract][Full Text] [Related]
39. LyP-1-conjugated nanoparticles for targeting drug delivery to lymphatic metastatic tumors. Luo G; Yu X; Jin C; Yang F; Fu D; Long J; Xu J; Zhan C; Lu W Int J Pharm; 2010 Jan; 385(1-2):150-6. PubMed ID: 19825404 [TBL] [Abstract][Full Text] [Related]
40. Development and characterization of sorafenib-loaded PLGA nanoparticles for the systemic treatment of liver fibrosis. Lin TsT; Gao DY; Liu YC; Sung YC; Wan D; Liu JY; Chiang T; Wang L; Chen Y J Control Release; 2016 Jan; 221():62-70. PubMed ID: 26551344 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]